If you have spent any time researching your symptoms online, you have probably encountered both "andropause" and "low testosterone" used almost interchangeably. They show up in the same searches, describe similar symptoms, and sometimes appear to mean exactly the same thing. But clinically, they are not identical — and understanding the difference matters more than you might expect, because it directly affects how your condition should be diagnosed, monitored, and treated.
Defining the Terms
Low Testosterone (Hypogonadism)
Low testosterone, or hypogonadism, is a broad clinical term that means your body is not producing enough testosterone. The Cleveland Clinic defines it as total testosterone levels below 300 ng/dL combined with clinical symptoms. Critically, low testosterone can occur at any age and from a wide range of causes:
- Primary hypogonadism — The testes themselves are the problem. Causes include Klinefelter syndrome, undescended testicles, testicular injury, mumps orchitis, cancer treatment (chemotherapy or radiation), or hemochromatosis.
- Secondary hypogonadism — The issue lies upstream, in the hypothalamus or pituitary gland. Causes include pituitary tumors, Kallmann syndrome, inflammatory diseases, HIV/AIDS, obesity, and certain medications (opioids, corticosteroids).
A 25-year-old man with a pituitary adenoma can have clinically low testosterone. So can a 35-year-old on long-term opioid therapy. Neither of these cases is andropause.
Andropause (Late-Onset Hypogonadism)
Andropause is a specific subset of hypogonadism. The preferred clinical term is late-onset hypogonadism (LOH), and it refers exclusively to the gradual, age-related decline in testosterone that occurs in middle-aged and older men. According to a review in the Indian Journal of Endocrinology and Metabolism, andropause is characterized by its insidious onset, slow progression, and the absence of any identifiable pathological cause beyond aging itself.
Put simply: all andropause involves low testosterone, but not all low testosterone is andropause.
The Clinical Overlap: Why Confusion Is Understandable
The symptoms of andropause and other forms of low testosterone are nearly identical. Whether your testosterone is low because of aging, a pituitary issue, or medication side effects, you are likely to experience some combination of:
- Fatigue and reduced energy
- Decreased libido and sexual dysfunction
- Loss of muscle mass and increased body fat
- Depressed mood, irritability, and cognitive fog
- Sleep disturbances
- Reduced bone density
This symptom overlap is exactly why many men — and even some providers — use the terms interchangeably. The symptoms feel the same regardless of the cause. But the cause determines the correct treatment pathway, which is why accurate diagnosis matters.
Diagnostic Criteria: How Clinicians Tell Them Apart
The diagnostic process for both conditions begins the same way: symptom assessment plus blood work. But the criteria and the investigative depth differ.
Diagnosing Low Testosterone (General Hypogonadism)
The Endocrine Society guidelines recommend:
- Two morning blood draws (before 10 AM) showing total testosterone below 300 ng/dL
- Measurement of free testosterone if total testosterone is borderline (200–400 ng/dL)
- LH and FSH testing to distinguish primary from secondary hypogonadism
- Additional testing as needed: prolactin, iron studies, pituitary MRI, karyotype, or semen analysis
The goal is to identify why testosterone is low. Is it the testes? The pituitary? A medication? An underlying disease? The answer shapes treatment.
Diagnosing Andropause (Late-Onset Hypogonadism)
The landmark European Male Aging Study (EMAS) established the most rigorous diagnostic criteria for LOH. To qualify, a man must have:
- Total testosterone below 11 nmol/L (approximately 317 ng/dL) and free testosterone below 220 pmol/L
- At least three sexual symptoms: erectile dysfunction, reduced frequency of morning erections, and decreased sexual thoughts
- No other identifiable cause for the testosterone deficiency (i.e., it is attributed to aging)
By these strict criteria, only about 2% of men aged 40–80 meet the full definition of LOH. However, a much larger percentage — perhaps 20–30% of men over 50 — have biochemically low testosterone with at least some symptoms, even if they do not meet every EMAS criterion. This is the gray zone where most real patients live, and where experienced clinical judgment becomes essential.
Why the Distinction Matters for Treatment
This is not an academic exercise. The difference between andropause and other forms of low testosterone has direct implications for how your provider should approach treatment.
When It Is Andropause (LOH)
Age-related testosterone decline is typically managed with a combination of:
- Testosterone replacement therapy (TRT) — The cornerstone treatment for confirmed LOH. Options include injections, topical gels, patches, or pellets. The Mayo Clinic notes that TRT can improve energy, libido, mood, and body composition in men with documented deficiency.
- Lifestyle optimization — Resistance training, improved sleep hygiene, stress reduction, and dietary changes that support hormonal health. These interventions can raise testosterone modestly on their own and amplify the benefits of TRT.
- Ongoing monitoring — Regular blood work to track testosterone levels, hematocrit, PSA, and metabolic markers to ensure safety and efficacy.
At Man UnPaused, our treatment program is built specifically around this model. We combine provider-supervised hormone therapy with lifestyle guidance and regular lab monitoring, all delivered through our telehealth platform.
When It Is Not Andropause
If your low testosterone stems from a different cause, the treatment approach may be fundamentally different:
- Pituitary disorders — May require surgery, radiation, or medications targeting the pituitary before testosterone can be addressed.
- Medication-induced low T — The first step is working with your prescriber to taper or switch the offending drug (commonly opioids, corticosteroids, or certain antidepressants).
- Obesity-driven low T — Significant weight loss alone can restore testosterone levels in some men, potentially avoiding the need for TRT entirely.
- Primary testicular failure — TRT is typically indicated, but fertility considerations require careful discussion since exogenous testosterone suppresses sperm production.
Skipping the diagnostic step and jumping straight to TRT without understanding the root cause can mean missing a treatable underlying condition or choosing the wrong therapy entirely.
The Terminology Problem in Men's Health
Part of the confusion stems from how loosely these terms are used outside of clinical settings. "Low T" has become a marketing buzzword. "Andropause" gets treated as a catch-all. And "male menopause" — while attention-grabbing — is considered misleading by many endocrinologists because it implies a parallel to female menopause that does not hold up physiologically.
The Journal of Clinical and Diagnostic Research notes that even within the medical community, there is ongoing debate about the best terminology. What matters for you as a patient is not which label gets used, but whether your provider conducts a thorough evaluation that identifies the specific cause of your symptoms and tailors treatment accordingly.
How to Know Which One You Have
You cannot self-diagnose the difference between andropause and other causes of low testosterone. That requires lab work and clinical evaluation. But you can take meaningful first steps:
- Assess your symptoms — Our free screening quiz helps you catalog the specific symptoms you are experiencing and their severity.
- Get tested — A comprehensive hormone panel is the only way to confirm whether your testosterone is actually low and to begin identifying why.
- Work with specialists — General practitioners may check testosterone but often lack the training to interpret nuanced results or distinguish between LOH and other causes. Providers who specialize in men's hormonal health — like our team at Man UnPaused — are equipped to make that distinction and build a treatment plan around it.
The Bottom Line
Andropause and low testosterone are related but distinct. Andropause (late-onset hypogonadism) is a specific, age-driven form of low testosterone that primarily affects men over 40. Low testosterone is a broader category that includes andropause but also encompasses conditions caused by genetics, disease, injury, or medications at any age.
The symptoms may feel identical, but the diagnosis and treatment should not be one-size-fits-all. Getting the right answer starts with a thorough evaluation. If you are experiencing fatigue, low libido, weight gain, or mood changes, take our free 3-minute screening quiz or explore our services to understand your options.
References
- Cleveland Clinic. Low Testosterone (Male Hypogonadism). Cleveland Clinic
- Singh P. Andropause: Current concepts. Indian J Endocrinol Metab. 2013;17(Suppl 3):S621-S629. PMC4046605
- Tajar A, et al. Late-onset hypogonadism: Current concepts and controversies. Asian J Androl. 2012. PMC3955328
- Bhasin S, et al. Diagnosis of Hypogonadism: Clinical Assessments and Laboratory Tests. PMC1472884
- Mayo Clinic Staff. Male menopause: Myth or reality? Mayo Clinic